Classes
Publications
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- SARS-CoV-2 Specific Humoral Immune Responses after BNT162b2 Vaccination in Hospital Healthcare Workers2022 | First Faculty of Medicine
- Neurofilament levels are associated with blood-brain barrier integrity, lymphocyte extravasation, and risk factors following the first demyelinating event in multiple sclerosis2021 | First Faculty of Medicine
- Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Toxocara spp. seronegativity in Czech patients with early form of multiple sclerosis - Clinically isolated syndrome2017 | First Faculty of Medicine
- CXCR3, CCR5, and CRTH2 Chemokine Receptor Expression in Lymphocytes Infiltrating Thyroid Nodules with Coincident Hashimoto's Thyroiditis Obtained by Fine Needle Aspiration Biopsy2016 | First Faculty of Medicine
- Toxocara canis larvae reinfecting BALB/c mice exhibit accelerated speed of migration to the host CNS2011 | First Faculty of Medicine, Third Faculty of Medicine
- Rituximab in hands of a nephrologist - first experience2009 | First Faculty of Medicine
- Retrospective assessment of routine ANCA detection: long-term single-centre experiencePublication without faculty affiliation
- Long-term follow-up of lymphocyte subpopulations and intracellular cytokines in patients with ANCA-associated vasculitis treated with rituximabPublication without faculty affiliation
Loading network view...